Rapport Therapeutics Inc (RAPP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RAPP | NEO | AAPG | ||
| Company | Rapport Therapeutics Inc | Neogenomics Inc | Ascentage Pharma Group Intl ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 39.81 | 14.52 | 19.00 | ||
| High | 40.57 | 14.98 | 19.00 | ||
| Low | 38.62 | 14.45 | 19.00 | ||
| Latest | 40.13 | 14.84 | 19.00 | ||
| Change | +0.20 | +0.34 | -1.40 | ||
| % Change | +0.50% | +2.34% | -6.86% | ||
| Volume | 350,600 | 4,269,900 | 851 | ||
| 20-Day Average Volume | 478,110 | 3,916,880 | 18,458 | ||
| Previous Close | 39.93 | 14.50 | 20.40 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 39.84 | 13.72 | 18.40 | ||
| 20-Day Raw Stochastic | 50.27% | 86.25% | 65.35% | ||
| 20-Day Relative Strength | 53.75 | 68.57 | 49.20 | ||
| Weighted Alpha | +95.56 | +106.62 | -52.50 | ||
| Today's Opinion | 100% Buy | 88% Buy | 64% Sell | ||
| Previous Opinion | 100% Buy | 88% Buy | 56% Sell | ||
| Last Month's Opinion | 100% Buy | 40% Buy | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -4.57% since 07/09/26 | +0.75% since 07/09/26 | -4.86% since 07/10/26 | ||
| Low | 38.62 on 07/16/26 | 13.80 on 07/14/26 | 18.99 on 07/14/26 | ||
| High | 42.65 on 07/13/26 | 14.98 on 07/16/26 | 20.40 on 07/16/26 | ||
| 1-Month | |||||
| %Chg | +4.26% since 06/16/26 | +41.47% since 06/16/26 | +11.18% since 06/17/26 | ||
| Low | 36.46 on 06/18/26 | 10.26 on 06/17/26 | 16.36 on 06/26/26 | ||
| High | 43.76 on 06/30/26 | 15.57 on 07/06/26 | 20.40 on 07/16/26 | ||
| 3-Month | |||||
| %Chg | +1.49% since 04/16/26 | +81.86% since 04/16/26 | -30.66% since 04/17/26 | ||
| Low | 32.41 on 04/30/26 | 7.69 on 04/23/26 | 16.36 on 06/26/26 | ||
| High | 43.76 on 06/30/26 | 15.57 on 07/06/26 | 26.72 on 04/21/26 | ||
| 6-Month | |||||
| %Chg | +49.68% since 01/16/26 | +16.03% since 01/16/26 | -29.76% since 01/16/26 | ||
| Low | 25.21 on 02/05/26 | 7.07 on 03/30/26 | 16.36 on 06/26/26 | ||
| High | 43.76 on 06/30/26 | 15.57 on 07/06/26 | 28.06 on 04/06/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,919,297 | 1,932,346 | 1,905,136 | ||
| Shares Outstanding, K | 47,827 | 130,212 | 93,389 | ||
| Annual Sales | 0 | 727,330,000 | 82,100,000 | ||
| Annual Net Income | -111,480,000 | -108,030,000 | -177,710,000 | ||
| Last Quarter Sales | 20,000,000 | 186,670,000 | N/A | ||
| Last Quarter Net Income | -19,860,000 | -17,110,000 | N/A | ||
| 60-Month Beta | 0.94 | 1.74 | 0.09 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.42 on 05/07/26 | 0.01 on 04/28/26 | N/A | ||
| Earnings Date | 08/06/26 | 07/28/26 | 03/25/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||